Related Experiment Video
Updated: Jun 27, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Statins in Chronic Liver Disease: Review of the Literature and Future Role
Nguyen Pham1, Jihane N Benhammou1,2,3
1Department of Medicine, University of California, Los Angeles, Los Angeles, California.
Insights
Statins show promise in managing chronic liver disease (CLD) and preventing liver cancer. Their anti-inflammatory and immune-protective effects offer potential benefits beyond cholesterol reduction for liver health.
Area of Science:
- Hepatology and Pharmacology
- Translational Medicine
Background:
- Chronic liver disease (CLD) presents a significant global health challenge with limited therapeutic advancements.
- Statins, primarily used for cardiovascular disease, are increasingly recognized for their potential in liver disease management.
Purpose of the Study:
- To review the clinical benefits of statins in various chronic liver disease (CLD) etiologies and hepatocellular carcinoma (HCC).
- To explore the multifaceted mechanisms of action of statins relevant to liver health.
- To discuss the potential role of statins in precision hepatology.
Main Methods:
- Comprehensive literature review of studies investigating statin use in CLD and HCC.
- Analysis of preclinical and clinical data on statin mechanisms in liver disease.
- Exploration of emerging evidence on genetic influences on statin efficacy.
Main Results:
- Statins exhibit anti-inflammatory, antiproliferative, and immune-protective effects beneficial for liver health.
- Evidence suggests clinical benefits of statins across viral and nonviral CLD, and in HCC treatment.
- The chemopreventive role of statins in CLD may offer the most substantial impact.
Conclusions:
- Statins possess pleiotropic effects that extend their utility to CLD management and prevention.
- Further research is warranted to elucidate the role of statins in precision hepatology, considering genetic variations.
- Statins represent a promising therapeutic avenue for improving outcomes in patients with chronic liver disease.
Abstract:
Chronic liver disease (CLD) is a major contributor to global mortality, morbidity, and healthcare burden. Progress in pharmacotherapeutic for CLD management is lagging given its impact on the global population. While statins are indicated for the management of dyslipidemia and cardiovascular disease, their role in CLD prevention and treatment is emerging. Beyond their lipid-lowering effects, their liver-related mechanisms of action are multifactorial and include anti-inflammatory, antiproliferative, and immune-protective effects. In this review, we highlight what is known about the clinical benefits of statins in viral and nonviral etiologies of CLD and hepatocellular carcinoma (HCC), and explore key mechanisms and pathways targeted by statins. While their benefits may span the spectrum of CLD and potentially HCC treatment, their role in CLD chemoprevention is likely to have the largest impact. As emerging data suggest that genetic variants may impact their benefits, the role of statins in precision hepatology will need to be further explored.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

